Hong Kong Sanatorium and Hospital Choose RayStation
RaySearch Laboratories AB (publ) announces that Hong Kong Sanatorium & Hospital has placed an order for RayStation®* as a treatment planning system for its proton therapy center.
STOCKHOLM, April 4, 2022 /PRNewswire/ — RaySearch has a strong position in the proton therapy market by hong kong. With the new RayStation order from Hong Kong Sanatorium & Hospital, it is further strengthened and the market share is now around 30%.
Hong Kong Sanatorium & Hospital proton therapy center installs Hitachi PROBEAT-V proton therapy system. The center-selected RaySearch software includes advanced technologies such as IMPT (Intensity Modulated Proton Therapy), multi-criteria optimization and comprehensive adaptive planning capabilities, as well as conventional IMRT/VMAT photonic planning (Intensity Modulated Radiotherapy). intensity therapy and volumetrically modulated arc therapy) and Accuray’s Radixact system planning.
George ChiuHead of Radiation Therapy Department, Hong Kong Sanatorium & Hospital, says, “We were looking for the best scheduling system for our proton facility, we finally found that RayStation could provide the best flexibility and synergy in our environment with all the different machines, like CyberKnife, Radixact and Versa HD. Their AI functionality is also impressive and will help us a lot in our future development.”
Johan Löf, Founder and CEO of RaySearch, said: “We are pleased to welcome Hong Kong Sanatorium & Hospital as our first customer in hong kong in the proton therapy segment and we look forward to a rewarding collaboration and the opportunity to help improve care for hospital patients. »
RaySearch Laboratories AB (publ) is a medical technology company that develops innovative software solutions to improve cancer treatment. RaySearch markets the RayStation®* treatment planning system (TPS) and the RayCare®* oncology information system (OIS). The most recent additions to the RaySearch product line are RayIntelligence® and RayCommand®. RayIntelligence is an oncology analytics system (OAS) that enables cancer clinics to collect, structure and analyze data. RayCommand, a treatment control system (TCS), is designed to link the treatment machine and the treatment planning and oncology information systems.
RaySearch software is used by over 800 clinics in over 40 countries. The company was founded in 2000 as a spin-off from the Karolinska Institute in stockholm and the stock has been listed on Nasdaq Stockholm since 2003. More information is available at raysearchlabs.com.
RayStation®* is a flexible and innovative treatment planning system chosen by many leading cancer centers around the world. It combines unique features such as unrivaled adaptive therapy capabilities, multi-criteria optimization, market leading algorithms for optimizing treatment plans for HDR brachytherapy and external beam therapy with photons, electrons and protons , as well as helium and carbon ions. RayStation supports a wide range of treatment machines, providing a control center for all treatment planning needs and ensuring centers get greater value from existing equipment. RayStation also integrates seamlessly with RayCare®*. By harmonizing treatment planning, the care of cancer patients worldwide is improved.
* Subject to regulatory approval in certain markets.
For more information please contact:
Johan Löf, Founder and CEO, RaySearch Laboratories AB (publ)
Telephone: +46 (0)8 510 530 00, [email protected]
Torbjörn Wingårdh, Chief Financial Officer, RaySearch Laboratories AB (publ)
Telephone: +46 (0)72 582 55 63, [email protected]
This information was brought to you by Cision http://news.cision.com
The following files are available for download:
SOURCE RaySearch Laboratories